Hundreds of British children with Type 2 diabetes who currently manage their condition with ‘burdensome’ finger prick blood testing several times a day could be
A potential stem cell–derived pancreatic islet cell replacement therapy (VX-880, from Vertex Pharmaceuticals) continues to show promise as a treatment for Type 1 diabetes, according
Substantial reductions in body weight across body mass index (BMI) categories, as well as improved body composition, were achieved with tirzepatide (Mounjaro) in adults for
A new study commissioned by Dexcom has found that 84% of people surveyed agreed that having diabetes can negatively impact mental health. The study also
Diabetes UK (DUK) has marked Diabetes Week by launching a campaign to call for fair and equal access to diabetes tech. A recent DUK press
A new guideline from the World Health Organization (WHO) on nonsugar sweeteners (NSSs) recommends not using them to control weight or to reduce the risk
A £5m funding award has been given to three researchers that have worked with DRWF. The funding marks the start of the Type 1 Diabetes
One of our regular advertisers (supporters we like to call them), Ascensia, has asked us to help them with a short survey about peoples’ habits
New research has found that treatment with metformin is significantly linked with reduced mortality in people with Type 2 diabetes, compared with treatment with other
Ypsomed is to expand its offering of digital health solutions in partnership with S3 Connected Health. Headquartered in Dublin, S3 Connected Health is a specialist
